Dialogue with HighTide Therapeutics’ CMO Dr. Filip Surmont: Moving Beyond the “Blockbuster” Legacy to Reshape Kidney Disease Treatment Through a Dual-Mechanism Approach
TransNusa Strengthens Domestic Network Connection with New Route Launch and Increased Scheduled Flight Frequency
RMB 2 Billion Investment Leverages Approximately RMB 8 Billion in Book Value Gains: Shoucheng Holdings (0697.HK) Enters the Monetization Phase of Its Robotics Investments
Datavault AI Inc. (NASDAQ: DVLT) and Demora Foundation Execute Technology Integration Agreement to Power the K-Entertainment & K-Wave Global Platform
